£111.67

This is the most expensive it has ever been. Walk away.

£112 today · previous high £112 · all-time low £104

Springer Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 76 days · 76 data points (no recent data)

Historical
Generating forecast…
£111.67 £103.61 £105.37 £107.13 £108.88 £110.64 £112.40 25 July 2026 12 August 2026 31 August 2026 19 September 2026 08 October 2026
View at Amazon ↗

Price data last checked 15 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 76 days • 2 price levels

Days at Price
Current Price
58 days 18 days · current 0 15 29 44 58 £104 £112 Days at Price

Price Analysis

Most common price: £104 (58 days, 76.3%)

Price range: £104 - £112

Price levels: 2 different prices over 76 days

Description

This comprehensive clinical resource provides up-to-date information on plasma cell neoplasms and multiple myeloma management. The book covers new diagnostic criteria for symptomatic multiple myeloma requiring treatment and describes novel therapies recently approved by the U.S. Food and Drug Administration. It includes detailed information on lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed and refractory myeloma, ibrutinib for Waldenstrom's macroglobulinemia, and emerging therapeutic regimens. This authoritative Springer publication serves as an essential reference for healthcare practitioners, oncologists, haematologists, and internal medicine specialists seeking current clinical guidance and evidence-based treatment protocols for plasma cell malignancies.

Key Features

Covers new diagnostic criteria for symptomatic multiple myeloma requiring treatment according to current clinical standards.

Describes lenalidomide, panobinostat, bortezomib, dexamethasone, and ibrutinib as recently FDA-approved therapies for myeloma and related plasma cell neoplasms.

Provides comprehensive information on treatment options for relapsed and refractory myeloma cases.

Addresses ibrutinib therapy specifically for Waldenstrom's macroglobulinemia management.

Authored by Springer as an authoritative clinical reference for oncology and haematology practitioners.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
07 September 2016
Listed Since
10 September 2015

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
99% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 11 Sep 2026
Treatment of Multiple Myeloma and Related Disorders
98% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 17 Sep 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
98% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£104.67 24 Sep 2026
Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)
98% match

Plasma Cell Dyscrasias: 169 (Cancer Treatment and Research, 169)

Springer

£80.64 08 Sep 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 12 Aug 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
98% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£148.94 14 Aug 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
98% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£61.58 23 Sep 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
97% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£92.80 25 Sep 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£80.67 24 Sep 2026
Advances in Biology and Therapy of Multiple Myeloma Volume 2
97% match

Advances in Biology and Therapy of Multiple Myeloma Volume 2

Springer

£111.90 13 Oct 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£73.48 13 Oct 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.27 13 Aug 2026
Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)
97% match

Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

CRC Press

£91.79 06 Oct 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
97% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£140.60 14 Aug 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
97% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£83.26 09 Oct 2026
Contemporary Management of Multiple Myeloma
97% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£39.79 22 Sep 2026
Recent Updates on Multiple Myeloma
97% match

Recent Updates on Multiple Myeloma

IntechOpen

£119.00 24 Sep 2026
Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)
97% match

Multiple Myeloma: Risk Factors, Diagnosis & Treatments (Cancer Etiology, Diagnosis and Treatments)

£130.52 15 Aug 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 12 Sep 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
96% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 04 Oct 2026
Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)
96% match

Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)

Springer

£114.51 17 Oct 2026
Molecular Aspects of Hematologic Malignancies - Diagnostic Tools
96% match

Molecular Aspects of Hematologic Malignancies - Diagnostic Tools

Springer

£112.14 05 Oct 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
96% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Elsevier

£167.99 22 Aug 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£144.43 20 Aug 2026